Clinical trial
Patient-derived Organoids As Predictive Models for Drug Response Testing and Repurporsing in Glioblastoma Therapy
NCT06782984 is registered in ClinicalTrials.gov with Chungnam National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient-derived Organoids As Predictive Models for Drug Response Testing and Repurporsing in Glioblastoma Therapy
- Lead sponsor
- Chungnam National University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 18, 2021
- Completion date
- December 31, 2030
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glioblastoma, organoid